The Oral-Systemic Connection: How Your Mouth Bacteria Shape Your Brain, Heart, and Metabolism

You are brushing your teeth to save your smile. You should be tending your oral microbiome to save your brain.

This is not hyperbole. A revolution in medical research now links the state of your oral microbiome to your risk of Alzheimer’s disease, heart attacks, and diabetes. Meanwhile, certain tongue bacteria perform an essential cardiovascular function that antibacterial mouthwashes may be destroying. The emerging science suggests that how you care for your mouth could influence how long and how well you live.

The wellness world has spent the last decade obsessing over the gut microbiome. Bookstores overflow with titles on probiotics, prebiotics, and fermented foods. Yet this focus on the “downstream” organ has ignored a critical fact: the mouth is the upstream source. Anatomically and physiologically, digestion begins in the oral cavity. Swallowing saliva introduces billions of bacteria into the digestive tract every day. Ignoring the mouth while treating the gut is, biologically speaking, like trying to clean a river while ignoring the factory polluting the source.

What follows is the case for why oral health may be the most overlooked pillar of wellness, and what you can do about it.

Part One: The Brain Connection

A Mouth Bacterium Found in Alzheimer’s Brains

In January 2019, a landmark study in Science Advances sent shockwaves through the medical community. Researchers led by Stephen Dominy found the bacterium Porphyromonas gingivalis, the keystone pathogen behind chronic gum disease, inside the brains of Alzheimer’s patients. The study detected P. gingivalis DNA in the cerebrospinal fluid of 7 of 10 living patients diagnosed with probable Alzheimer’s, and its toxic enzymes, called gingipains, were present in 91–96% of postmortem Alzheimer’s brain samples examined.

This was not contamination. Gingipain levels were significantly higher in Alzheimer’s brains than in controls, and they correlated strongly with tau protein tangles, the hallmark pathology of the disease. When the researchers orally infected mice with P. gingivalis, the bacteria colonized their brains within 6 weeks and triggered increased production of amyloid-beta, another protein that accumulates in Alzheimer’s brains.

How a Mouth Bacterium Reaches the Brain

How does a mouth bacterium reach the brain? P. gingivalis employs multiple routes. It can infect monocytes, a type of white blood cell, that subsequently traffic across the blood-brain barrier. Its gingipains directly degrade tight junction proteins that seal the barrier. The bacterium can also travel via the olfactory and trigeminal nerves, which provide direct pathways from the mouth and nasal passages to the brain. Research published in the International Journal of Oral Science in 2023 demonstrated that P. gingivalis bacteremia increases blood-brain barrier permeability through a specific transcytosis pathway.

Once in the brain, gingipains wreak havoc. These cysteine proteases cleave tau protein at multiple sites, generating tau fragments that nucleate the paired helical filaments forming neurofibrillary tangles. Studies have shown that P. gingivalis-infected human neurons lost 25% of cells over 72 hours, with accumulation of autophagic vacuoles, cytoskeletal disruption, and synapse loss.

The Epidemiological Evidence

The epidemiological evidence aligns with these mechanistic findings. A 2024 meta-analysis found that periodontitis was associated with dementia at an odds ratio of 2.26, meaning people with gum disease had more than double the odds of developing dementia. A large Taiwanese cohort study following over 9,000 patients found that 10-year exposure to chronic periodontitis increased Alzheimer’s risk by 70%. A global estimate suggests that a 50% reduction in periodontal disease prevalence could prevent 850,000 dementia cases worldwide.

Part Two: The Heart Connection

Oral Bacteria Living in Clogged Arteries

The connection between gum disease and heart disease has been recognized for decades, but recent research reveals just how direct this link can be. Oral bacteria have been found alive inside atherosclerotic plaques, not as passive bystanders but as active contributors to cardiovascular disease.

In 2005, University of Florida researchers made a breakthrough discovery: they detected live periodontal bacteria in human atherosclerotic plaques, the first “smoking gun” evidence that these organisms become permanent inhabitants of vessel walls. Earlier work had found that 44% of carotid artery plaques tested positive for at least one periodontal pathogen, with P. gingivalis present in 26% of samples.

A comprehensive meta-analysis published in npj Biofilms and Microbiomes identified 23 bacterial species in human atherosclerotic plaques, with five bacteria unique to coronary arteries: Campylobacter rectus, P. gingivalis, P. endodontalis, Prevotella intermedia, and Prevotella nigrescens. P. gingivalis detection rates reached 39.3% in coronary arteries and 26.7% in carotid arteries.

Oral Bacteria Transform Stable Plaques into Dangerous Ones

Perhaps most alarming is a 2025 study in the Journal of the American Heart Association that found viridans streptococci, common oral bacteria, present as biofilms in nearly 90% of advanced atherosclerotic lesions and ruptured plaques, compared to far fewer early-stage plaques. These bacteria appear to transform stable plaques into rupture-prone lesions, the kind that cause heart attacks. The same study linked streptococcal presence to more severe atherosclerosis and deaths from coronary heart disease.

The Mechanisms Explained

The mechanisms are now well understood. P. gingivalis invades endothelial cells through specific receptor-mediated pathways, using fimbriae proteins for adhesion and exploiting autophagy pathways to survive. Inside vessel walls, these bacteria activate inflammatory signaling cascades and inflammasomes, generating oxidative stress that damages the endothelium. They promote foam cell formation by increasing fat uptake in macrophages while reducing cholesterol efflux. They stimulate proliferation and calcification of vascular smooth muscle cells.

Just as “leaky gut” became a household term in the last decade, “leaky mouth” is the next frontier in inflammation research. When the gums are inflamed (gingivitis or periodontitis), the epithelial barrier becomes permeable. This allows oral bacteria and inflammatory cytokines to enter the bloodstream continuously, a phenomenon called bacteremia. These pathogens can travel to the heart, joints, and pancreas, seeding inflammation far from their original sites.

The systemic inflammatory response compounds these direct effects. Periodontal infection elevates C-reactive protein, interleukin-6, and tumor necrosis factor-alpha, all of which are markers and mediators of cardiovascular risk. A meta-analysis in Frontiers in Immunology provided robust evidence that periodontitis is associated with systemic inflammation as measured by serum CRP levels. Patients with aggressive periodontitis showed more than 50% higher CRP levels than those with chronic periodontitis.

Quantifying the Cardiovascular Toll

Meta-analyses consistently quantify the cardiovascular toll. An analysis of 39 cohort studies with over 4.3 million individuals found periodontal disease increased the risk of major adverse cardiovascular events by 24%, myocardial infarction by 14%, and cardiac death by 42%. For stroke, the risk is even more striking: an early meta-analysis found a 185% increased risk in people under 65 with periodontitis.

Part Three: The Diabetes Connection

A Vicious Bidirectional Cycle

The relationship between periodontal disease and diabetes exemplifies how oral health is connected to systemic metabolism. Each condition worsens the other, creating a destructive feedback loop that can be interrupted by treating either problem.

People with diabetes are approximately three times more likely to develop periodontitis than non-diabetics. A 20-year prospective study following over 35,000 men found that those with type 2 diabetes had a 29% increased risk of developing periodontitis and a 10% higher risk of tooth loss. A comprehensive meta-analysis of 53 studies found that diabetics had deeper periodontal pockets, more clinical attachment loss, and approximately two more missing teeth than non-diabetics.

How Diabetes Impairs Periodontal Health

Diabetes impairs periodontal health through multiple mechanisms. Hyperglycemia leads to the formation of advanced glycation end products (AGEs), which accumulate in gum tissues. When AGEs bind their receptor (RAGE), they trigger activation of the inflammatory pathway, pro-inflammatory cytokine production, and the release of tissue-destructive enzymes. Research has found that serum AGE levels are significantly associated with periodontitis progression in diabetic patients. AGEs also cross-link collagen, impairing wound healing and tissue repair. Meanwhile, neutrophil function becomes compromised: while their numbers increase, their ability to fight bacteria declines.

How Gum Disease Worsens Diabetes

The reverse direction of this relationship is equally important. A meta-analysis of 15 cohort studies with over 427,000 participants found that periodontitis increased the risk of developing diabetes by 26%. Severe periodontitis increased the incidence of type 2 diabetes by 53%. The mechanism involves chronic systemic inflammation: periodontal bacteria and their lipopolysaccharides trigger the release of inflammatory cytokines, which impair insulin receptor signaling, inhibit glucose transporter expression, and contribute to insulin resistance.

Treating Gum Disease Improves Diabetic Outcomes

The most clinically actionable finding is that treating gum disease improves diabetic outcomes. A 2022 Cochrane systematic review analyzed 35 randomized controlled trials and concluded there is moderate-certainty evidence that periodontal treatment improves glycemic control. The benefit persists for up to 12 months after treatment. Meta-analyses estimate HbA1c reductions of 0.3–0.5%, equivalent to adding a second diabetes medication. A Taiwanese study found that diabetic patients receiving advanced periodontal treatment had an 8% lower risk of myocardial infarction and 40% lower risk of heart failure compared to untreated patients.

Part Four: Your Tongue as a Blood Pressure Regulator

The Nitric Oxide Pathway You Have Never Heard Of

Perhaps the most surprising connection between oral health and systemic disease involves a biochemical pathway that most people, and many doctors, have never heard of. The bacteria living in the crypts of your tongue’s posterior surface perform an essential cardiovascular function: converting dietary nitrates into nitric oxide, a molecule critical for blood pressure regulation.

When you eat nitrate-rich vegetables like spinach, beetroot, or arugula, about 25% of the absorbed nitrate gets concentrated in your saliva at levels 10–20 times higher than in your blood. Bacteria on your tongue, including species of Neisseria, Haemophilus, Rothia, and Veillonella, then reduce this nitrate to nitrite using bacterial nitrate reductase enzymes. Humans cannot perform this conversion; we lack functional nitrate reductase.

Once swallowed, nitrite is converted to nitric oxide through multiple pathways, in the acidic stomach and through reactions with deoxyhemoglobin in the blood. This “enterosalivary” pathway contributes up to 25% of the body’s plasma nitrite levels and becomes increasingly important as we age or develop conditions that impair the classical nitric oxide production pathway.

Nitric oxide is the body’s primary vasodilator. It activates enzymes in vascular smooth muscle, leading to relaxation and a reduction in blood pressure. Meta-analyses of at least 19 studies confirm that dietary nitrate supplementation predictably lowers blood pressure. Randomized, double-blind, placebo-controlled trials have demonstrated sustained reductions in blood pressure in hypertensive patients.

Antibacterial Mouthwashes Destroy This Pathway

Here is the problem: antibacterial mouthwashes destroy these beneficial bacteria. A pivotal study from Queen Mary University of London found that using 0.2% chlorhexidine mouthwash twice daily for seven days reduced oral nitrite production by 90% and plasma nitrite levels by 25%. The same study documented systolic and diastolic blood pressure increases of 2–3.5 mmHg, a seemingly small change but one associated with a 10% increased risk of stroke mortality and 7% increased risk of death from ischemic heart disease.

Subsequent research has reinforced these findings. One study found that just three days of antibacterial mouthwash use increased systolic blood pressure by 2.3 mmHg in treated hypertensive patients. A study from the University of Plymouth showed that antibacterial mouthwash reduced the blood pressure-lowering effect of exercise by more than 60% in the first hour of recovery and completely abolished it by two hours.

Longitudinal Evidence

The most concerning data comes from longitudinal studies. The San Juan Overweight Adults Longitudinal Study followed 540 participants for 3 years and found that people using mouthwash twice daily or more had an 85% higher incidence of hypertension than less frequent users and a 117% higher incidence than non-users. The same cohort showed a 55% increased risk of developing prediabetes or diabetes with frequent mouthwash use.

A systematic review noted that 0.12% chlorhexidine mouthwash destroys up to 94% of oral nitrate-reducing bacteria and decreases nitrate reduction by 85%. Multiple antiseptic agents appear to have similar effects: chlorhexidine, essential oils (Listerine-type mouthwashes), hydrogen peroxide, cetylpyridinium chloride, chlorine dioxide, and povidone iodine all reduce nitric oxide production.

Part Five: A Biohacker’s Guide to the Mouth

Understanding the oral-systemic connection transforms how we should think about oral care. Rather than indiscriminately killing mouth bacteria, the goal should be cultivating a healthy oral microbiome while protecting the beneficial species that serve systemic functions.

Here is the remarkable thing about oral health optimization: unlike continuous glucose monitors, expensive supplements, or longevity-focused interventions that cost thousands of dollars, the protocols that follow are accessible to nearly everyone. The same people tracking their sleep scores and HRV often ignore the rich data stream from their mouths because they lack the tools and knowledge to interpret it. This section changes that.

Dietary Protocols: Feeding Your Oral Microbiome

Dietary strategies that support oral health begin with nitrate-rich vegetables. A University of Exeter study found that 10-day supplementation with beetroot juice in older adults increased health-associated bacteria (Neisseria, Haemophilus) while decreasing inflammation-promoting bacteria (Prevotella-Veillonella). A systematic review in Critical Reviews in Food Science and Nutrition found that dietary nitrate increases salivary pH and decreases gingival inflammation. The anti-cariogenic effects are real: high salivary nitrate concentrations are linked to lower cavity rates through growth inhibition of cariogenic bacteria.

Polyphenol-rich foods also beneficially reshape the oral microbiome. Research has found that green tea consumption alters the oral microbiome, shifting the composition of Streptococcus and Staphylococcus. Tea polyphenols, particularly EGCG, increase beneficial Bifidobacterium while decreasing pathogenic Clostridium species. Conversely, high sugar intake causes significant decreases in oral microbiome diversity and enrichment of disease-causing bacteria, such as S. mutans, Scardovia, and Lactobacillus.

Foods to emphasize include leafy greens (spinach, arugula, lettuce), beetroot and beet juice, celery, green tea and matcha, berries and other polyphenol-rich fruits, fermented vegetables, and high-fiber foods that promote saliva production. Foods to minimize include refined sugars, processed carbohydrates, acidic beverages, and alcohol.

Oral Probiotics: Seeding the Mouth with Beneficial Bacteria

Oral probiotics represent an emerging intervention with moderate clinical evidence. The best-studied strains are Streptococcus salivarius K12 and M18, originally isolated from healthy individuals in New Zealand. K12 produces two lantibiotics, salivaricin A2 and salivaricin B, that inhibit pathogenic bacteria through competitive exclusion. In clinical trials, K12 reduced streptococcal pharyngeal infections by more than 90% in children with recurrent infections. M18, which specifically targets cavity-causing S. mutans, significantly improved periodontal parameters in patients with Stage III/IV periodontitis when used as an adjunct to treatment.

Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289, marketed as “Prodentis”) has accumulated strong evidence for periodontal benefits. A randomized trial in navy sailors found L. reuteri lozenges effectively maintained and improved periodontal health across all assessed parameters. A systematic review found that two-thirds of studies showed improved oral health outcomes with L. reuteri in conditions including caries, periodontal disease, candida infection, and halitosis.

Weissella cibaria CMU, dominant in fermented foods like kimchi, has demonstrated efficacy for halitosis. A randomized trial of 100 adults found significantly lower volatile sulfur compounds and improved bad breath scores after 8 weeks of supplementation.

When selecting oral probiotics, look for products containing documented strains (K12, M18, L. reuteri DSM 17938/ATCC PTA 5289), lozenges or slowly dissolving tablets (not capsules meant to be swallowed), adequate colony-forming units (typically 1 billion CFU or more), and use after brushing to allow colonization.

Airway Health: The Overlooked Factor

Airway practices matter more than most people realize. Mouth breathing during sleep creates a dry environment, fundamentally altering the oral microbiome. Research has found that mouth-breathing adolescents had a 4 times higher risk of developing high S. mutans counts than nasal breathers, even with professional oral hygiene. Chronic mouth breathing reduces salivary flow, diminishes acid-buffering capacity, and shifts oral pH toward conditions that favor cariogenic bacteria.

In children, the consequences extend to facial development. A meta-analysis found that mouth breathing significantly affects skeletal development, leading to “adenoid facies,” characterized by increased lower facial height, a narrow maxillary arch, a high palatal vault, and malocclusion. Early intervention for pediatric mouth breathing appears important for both dental and developmental outcomes.

Mouth taping during sleep has gained popular attention, though evidence remains limited. A preliminary study found that taping reduced the apnea-hypopnea index by approximately half in patients with mild obstructive sleep apnea. However, a 2024 systematic review found only minimal and uncertain evidence of benefits, noting the potentially serious risk of harm to individuals who indiscriminately practice this trend. Mouth taping should not be attempted by those with nasal obstruction, severe sleep apnea, or without medical consultation.

Nasal breathing exercises, such as those practiced in yoga (pranayama) or the Buteyko method, may help retrain breathing patterns. Addressing underlying nasal obstruction, whether from allergies, deviated septum, or enlarged turbinates, is essential before attempting to change breathing habits.

Product Guide: Choosing Microbiome-Friendly Dental Products

Product choices matter for the oral microbiome. The goal is to remove harmful biofilm and support remineralization without indiscriminately destroying beneficial bacteria.

Toothpaste: Nano-Hydroxyapatite vs. Fluoride

Nano-hydroxyapatite (nHA) toothpaste offers a biomimetic alternative to fluoride that does not disrupt oral bacteria. Research has found 10% nHA toothpaste showed up to 36% reduction in early enamel lesions, comparable to fluoride. Originally developed by NASA and commercialized in Japan since 1978, nHA mimics natural tooth enamel and is non-toxic if swallowed, making it suitable for children and individuals sensitive to fluoride.

Fluoride remains the most extensively studied remineralizing agent, but concerns exist about its effects on the oral microbiome and potential for fluorosis with excessive exposure. Both options are effective for remineralization; nHA may be preferable for those seeking to preserve microbiome diversity.

Mouthwash: pH-Balanced Rinses vs. Antibacterial Products

Alcohol-based mouthwashes disrupt the oral microbiome indiscriminately. A 2024 study from the Institute of Tropical Medicine in Antwerp found that daily Listerine Cool Mint use increased the abundance of Fusobacterium nucleatum and Streptococcus anginosus, bacteria linked to gum disease and colorectal cancer, while decreasing Actinobacteria, which are important for nitrate reduction.

Chlorhexidine, often prescribed after dental procedures, should be limited to short-term therapeutic use. Beyond its effects on the nitric oxide pathway, research has found that 7-day chlorhexidine use caused major shifts in salivary microbiome composition, lower salivary pH, and elevated lactate and glucose levels. The data suggest chronic chlorhexidine use creates conditions that may paradoxically worsen oral health.

Better alternatives include pH-balanced rinses (look for neutral pH around 7.0), xylitol-containing rinses (xylitol inhibits pathogenic bacteria without killing beneficial species), saltwater rinses (isotonic saline, about 1/2 teaspoon per cup), and baking soda rinses (alkaline pH counters acid attacks).

Tongue Cleaning

Tongue scraping has modest but real evidence for reducing halitosis. A Cochrane review found small but statistically significant advantages of tongue scrapers over toothbrushes for reducing volatile sulfur compounds. A randomized trial found tongue scraping reduced gingival inflammation alongside halitosis measures. Importantly, research has shown that tongue-cleaning frequency affects microbiome composition and enterosalivary nitrate circulation, linking this simple practice to the cardiovascular pathway.

Use a dedicated tongue scraper rather than a toothbrush, clean gently from back to front, and avoid excessive scraping that could damage the tongue surface or remove too many beneficial bacteria.

What to Avoid

Triclosan-containing products (being phased out but still found in some toothpastes), alcohol-based mouthwashes for daily use, harsh whitening products with high peroxide concentrations, and any antibacterial rinse as a daily habit should be avoided to protect the oral microbiome.

Conclusion: Your Mouth Bacteria Are Partners, Not Enemies

The oral-systemic connection fundamentally challenges the idea that mouth bacteria are simply enemies to be eliminated. P. gingivalis and other periodontal pathogens can indeed cause systemic harm, with now-compelling evidence linking them to Alzheimer’s disease, cardiovascular events, and diabetes. But tongue bacteria also perform essential cardiovascular functions that antiseptic mouthwashes destroy.

For decades, a bureaucratic accident of history has separated dentistry from medicine, treating the mouth as if it were disconnected from the body it inhabits. Your dental insurance is separate from your medical insurance. Your dentist and your physician rarely communicate. This artificial divide has left the mouth as a blind spot in whole-body health, even as the science has moved decisively in the opposite direction.

The implications are practical. Treat periodontal disease aggressively, because the more than doubled dementia risk, 24% increased cardiovascular risk, and bidirectional amplification of diabetes all argue for taking gum health seriously. But do not reach for antibacterial mouthwash as a daily ritual. Consider oral probiotics, particularly S. salivarius K12 and M18, or L. reuteri, which have moderate evidence of benefits. Eat nitrate-rich vegetables to feed your beneficial tongue bacteria. Choose nano-hydroxyapatite over harsh antiseptics. And if you are a mouth breather, addressing that problem may benefit far more than your teeth.

The science is still evolving. Mendelian randomization studies have produced mixed results on whether periodontal bacteria directly cause systemic disease or share risk factors with it. Clinical trials of gingipain inhibitors in Alzheimer’s disease have shown mixed cognitive outcomes. But the direction is clear: oral health is systemic health. What happens in your mouth does not stay in your mouth.

References

1. Acar B, Berker E, Tan Ç, et al. Effects of oral prophylaxis including tongue cleaning on halitosis and gingival inflammation in gingivitis patients: A randomized controlled clinical trial. Clinical Oral Investigations. 2019;23(4):1829-1836.
2. Amaechi BT, AbdulAzees PA, Alshareif DO, et al. Comparative efficacy of a hydroxyapatite and a fluoride toothpaste for prevention and remineralization of dental caries in children. BDJ Open. 2019;5:18.
3. Angarita-Díaz MDP, Fong C, Bedoya-Correa CM, Cabrera-Arango CL. Does high sugar intake really alter the oral microbiota?: A systematic review. Clinical and Experimental Dental Research. 2022;8(6):1376-1390.
4. Bescos R, Ashworth A, Cutler C, et al. Effects of chlorhexidine mouthwash on the oral microbiome. Scientific Reports. 2020;10(1):5254.
5. Blot S. Antiseptic mouthwash, the nitrate-nitrite-nitric oxide pathway, and hospital mortality: A hypothesis generating review. Intensive Care Medicine. 2021;47(1):28-38.
6. Bondonno CP, Liu AH, Croft KD, et al. Antibacterial mouthwash blunts oral nitrate reduction and increases blood pressure in treated hypertensive men and women. American Journal of Hypertension. 2015;28(5):572-575.
7. Chen CK, Wu YT, Chang YC. Association between chronic periodontitis and the risk of Alzheimer’s disease: A retrospective, population-based, matched-cohort study. Alzheimer’s Research & Therapy. 2017;9(1):56.
8. Chen L, Luo G, Xuan D, et al. Effects of non-surgical periodontal treatment on clinical response, serum inflammatory parameters, and metabolic control in patients with type 2 diabetes: A randomized study. Journal of Periodontology. 2012;83(4):435-443.
9. Cutler C, Kiernan M, Willis JR, et al. Post-exercise hypotension and skeletal muscle oxygenation is regulated by nitrate-reducing activity of oral bacteria. Free Radical Biology and Medicine. 2019;143:252-259.
10. Di Pierro F, Donato G, Fomia F, et al. Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media. International Journal of General Medicine. 2012;5:991-997.
11. Doel JJ, Benjamin N, Hector MP, et al. Evaluation of bacterial nitrate reduction in the human oral cavity. European Journal of Oral Sciences. 2005;113(1):14-19.
12. Dominy SS, Lynch C, Ermini F, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Science Advances. 2019;5(1):eaau3333.
13. Fiehn NE, Larsen T, Christiansen N, et al. Identification of periodontal pathogens in atherosclerotic vessels. Journal of Periodontology. 2005;76(5):731-736.
14. Guo X, Li X, Liao C, Feng X, He T. Periodontal disease and subsequent risk of cardiovascular outcome and all-cause mortality: A meta-analysis of prospective studies. PLOS ONE. 2023;18(9):e0290545.
15. Haditsch U, Roth T, Rodriguez L, et al. Alzheimer’s disease-like neurodegeneration in Porphyromonas gingivalis infected neurons with persistent expression of active gingipains. Journal of Alzheimer’s Disease. 2020;75(4):1361-1376.
16. Han HS, Yum H, Cho YD, Kim S. Improvement of halitosis by probiotic bacterium Weissella cibaria CMU: A randomized controlled trial. Frontiers in Microbiology. 2023;14:1108762.
17. Haraszthy VI, Zambon JJ, Trevisan M, et al. Identification of periodontal pathogens in atheromatous plaques. Journal of Periodontology. 2000;71(10):1554-1560.
18. Hyde ER, Andrade F, Vaksman Z, et al. Metagenomic analysis of nitrate-reducing bacteria in the oral cavity: Implications for nitric oxide homeostasis. PLOS ONE. 2014;9(3):e88645.
19. Hyink O, Wescombe PA, Upton M, et al. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Applied and Environmental Microbiology. 2007;73(4):1107-1113.
20. Janket SJ, Baird AE, Chuang SK, Jones JA. Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2003;95(5):559-569.
21. Jimenez M, Hu FB, Marino M, et al. Type 2 diabetes mellitus and 20 year incidence of periodontitis and tooth loss. Diabetes Research and Clinical Practice. 2012;98(3):494-500.
22. Jin JS, Touyama M, Hisada T, Benno Y. Effects of green tea consumption on human fecal microbiota with special reference to Bifidobacterium species. Microbiology and Immunology. 2012;56(11):729-739.
23. Jockel-Schneider Y, Goßner SK, Petersen N, et al. Stimulation of the nitrate-nitrite-NO-metabolism by repeated lettuce juice consumption decreases gingival inflammation in periodontal recall patients: A randomized, double-blinded, placebo-controlled clinical trial. Journal of Clinical Periodontology. 2016;43(7):603-608.
24. Joshipura K, Muñoz-Torres F, Fernández-Santiago J, et al. Over-the-counter mouthwash use, nitric oxide and hypertension risk. Blood Pressure. 2020;29(2):103-112.
25. Joshipura KJ, Muñoz-Torres FJ, Morou-Bermudez E, Patel RP. Over-the-counter mouthwash use and risk of pre-diabetes/diabetes. Nitric Oxide. 2017;71:14-20.
26. Kapil V, Haydar SM, Pearl V, et al. Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radical Biology and Medicine. 2013;55:93-100.
27. Kapil V, Khambata RS, Robertson A, et al. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: A randomized, phase 2, double-blind, placebo-controlled study. Hypertension. 2015;65(2):320-327.
28. Koch CD, Gladwin MT, Freeman BA, et al. Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health. Free Radical Biology and Medicine. 2017;105:48-67.
29. Laumen JGE, Van Dijck C, Manoharan-Basil SS, et al. The effect of daily usage of Listerine Cool Mint mouthwash on the oropharyngeal microbiome: A substudy of the PReGo trial. Journal of Medical Microbiology. 2024;73(6):001830.
30. Lee YC, Lu CT, Cheng WN, Li HY. The impact of mouth-taping in mouth-breathers with mild obstructive sleep apnea: A preliminary study. Healthcare. 2022;10(9):1755.
31. Lei S, Li J, Yu J, et al. Porphyromonas gingivalis bacteremia increases the permeability of the blood-brain barrier via the Mfsd2a/Caveolin-1 mediated transcytosis pathway. International Journal of Oral Science. 2023;15(1):3.
32. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-1913.
33. Nadim R, Tang J, Dilmohamed A, et al. Influence of periodontal disease on risk of dementia: A systematic literature review and a meta-analysis. European Journal of Epidemiology. 2020;35(9):821-833.
34. Nonaka S, Kadowaki T, Nakanishi H. Secreted gingipains from Porphyromonas gingivalis increase permeability in human cerebral microvascular endothelial cells through intracellular degradation of tight junction proteins. Neurochemistry International. 2022;154:105282.
35. Outhouse TL, Al-Alawi R, Fedorowicz Z, Keenan JV. Tongue scraping for treating halitosis. Cochrane Database of Systematic Reviews. 2006;(2):CD005519.
36. Preshaw PM, Alba AL, Herrera D, et al. Periodontitis and diabetes: A two-way relationship. Diabetologia. 2012;55(1):21-31.
37. Schlagenhauf U, Goetz H, Gelleric D, When M,.”Consumption of Lactobacillus reuteri-containing lozenges improves periodontal health in navy sailors at sea: A randomized controlled trial. Journal of Periodontology. 2020;91(10):1328-1338.
38. Simpson TC, Clarkson JE, Worthington HV, et al. Treatment of periodontitis for glycaemic control in people with diabetes mellitus. Cochrane Database of Systematic Reviews. 2022;4(4):CD004714.
39. Stöhr J, Barbaresko J, Neuenschwander M, Schlesinger S. Bidirectional association between periodontal disease and diabetes mellitus: A systematic review and meta-analysis of cohort studies. Scientific Reports. 2021;11(1):13686.
40. Takeda M, Ojima M, Yoshioka H, et al. Relationship of serum advanced glycation end products with deterioration of periodontitis in type 2 diabetes patients. Journal of Periodontology. 2006;77(1):15-20.
41. Tribble GD, Angelov N, Weltman R, et al. Frequency of tongue cleaning impacts the human tongue microbiome composition and enterosalivary circulation of nitrate. Frontiers in Cellular and Infection Microbiology. 2019;9:39.
42. Wang X, Han X, Guo X, et al. The effect of periodontal treatment on hemoglobin A1c levels of diabetic patients: A systematic review and meta-analysis. PLOS ONE. 2014;9(9):e108412.
43. Wu CZ, Yuan YH, Liu HH, et al. Epidemiologic relationship between periodontitis and type 2 diabetes mellitus. BMC Oral Health. 2020;20(1):204.
44. Yuan X, Long Y, Ji Z, et al. Green tea liquid consumption alters the human intestinal and oral microbiome. Molecular Nutrition & Food Research. 2018;62(12):e1800178.
45. Zhang J, Xie M, Huang X, et al. The effects of Porphyromonas gingivalis on atherosclerosis-related cells. Frontiers in Immunology. 2021;12:766560.
46. Zhao Z, Zheng L, Huang X, et al. Effects of mouth breathing on facial skeletal development in children: A systematic review and meta-analysis. BMC Oral Health. 2021;21(1):108.